Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2001

01-11-2001

Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)

Authors: Yoshiki Nishizawa, Toshitaka Nakamura, Hiroaki Ohata, Kazuhiro Kushida, Itsuo Gorai, Masataka Shiraki, Masao Fukunaga, Takayuki Hosoi, Takami Miki, Kiyoshi Nakatsuka, Masakazu Miura, for the Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis, Japan Osteoporosis Society

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2001

Login to get access
Metadata
Title
Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
Authors
Yoshiki Nishizawa
Toshitaka Nakamura
Hiroaki Ohata
Kazuhiro Kushida
Itsuo Gorai
Masataka Shiraki
Masao Fukunaga
Takayuki Hosoi
Takami Miki
Kiyoshi Nakatsuka
Masakazu Miura
for the Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis, Japan Osteoporosis Society
Publication date
01-11-2001
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2001
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s007740170002

Other articles of this Issue 6/2001

Journal of Bone and Mineral Metabolism 6/2001 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.